The company is unable to obtain information to further investigate this event due to a holiday in (b)(6).The company is submitting this mdr in compliance with 21 cfr part 803.The company will supplement this mdr with additional information, as necessary.Our preliminary investigation has identified the following: a) the intended use of the amnisure rom test, as written in the package insert, indicates that the test is an aid in the detection of rupture of fetal membranes (rom) in pregnant women.As a diagnostic aid, there is an expectation that patient care is based on a multitude of factors/tests/analyses.In this case, an initial ultrasound would have been useful as an additional tool in determining rom status and clinical actions.B) the attending physician was unable to confirm that the patient had been leaking amniotic fluid.Due to the patient's condition there may have been other clinical factors that attributed to her low amniotic fluid level, thus amnisure would have provided correct results.C) the company performed testing on retain samples for the lots implicated and all results passed specifications.Additionally, batch records were reviewed and all testing passed specifications with no deviations noted.
|